Overview
Novo is a pharmaceutical wholesaler and supplier offering a wide range of services for the pharmaceutical industry and healthcare sector. The company ensures stable distribution of pharmaceutical products from manufacturers to patients, adhering to Good Distribution Practice (GDP) standards. Novo operates in six provinces, providing pharmaceutical and medical products with a commitment to maintaining stock levels and stable pricing policies.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-07-30. Active
82 1600 1462 1739 7891 4000 0001- 17 1600 1462 1739 7891 4000 0007
98 2490 0005 0000 4520 2864 1385
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $515$515 | Tauron Sprzedaż sp. z o.o. | |
| Jul 29, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $20,001$20,001 | Fundusz Górnośląski S.A. |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Joint action by two members of the management board is required to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Dariusz Edward Gambuś (62)  | 50 % w podmiocie dominującym | |
Janusz Eugeniusz Nahorniak (68) | 50%udziałów w podmiocie dominującym |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| HurtapS.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.pl | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| NettleS.A. | $85,124,937.06 | nettle.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-29 | PKD change (Removed: 46.90.Z, 64.99.Z; Added: 68.20.Z, 82.30.Z) | |
| 2023-02-15 | Address change (Mikołowska 93, 43-100, Tychy → Ul. Mikołowska 232, 43-100, Tychy) | |
| 2015-09-02 | PKD change (Removed: 68.20.Z, 70.22.Z, 73.11.Z, 74.90.Z, 82.30.Z, 82.99.Z, 96.09.Z) | |
| 2011-11-18 | Share capital change (100,000.00 PLN → 1,333,000.00 PLN) | |
| 2010-07-15 | Entered in the register |
FAQ
Last updated: 2026-07-17